ZEMCELPRO is indicated as stem-cell medicine used to treat adults with hematological malignancies (blood cell cancers) who need an allogeneic hematopoietic stem cell transplantation (allo-HSCT) and for whom no other type of suitable donor cells is available. The information on this website is based on the Production Information

Legal Notice

Website Publisher

This website is published by:

Cordex Biologics International Ltd.
5th Floor, Block E, Iveagh Court, Harcourt Road
Dublin 2, Ireland D02 YT22

Email: info@cordexbio.com


Intended Audience

This website is intended for healthcare professionals and other stakeholders involved in hematopoietic stem cell transplantation and advanced cell therapies.

The information provided on this website is intended for information purposes only and does not replace the approved European Union Summary of Product Characteristics (SmPC).


Medical Information

Zemcelpro® should be prescribed and administered by qualified healthcare professionals in specialized transplant centers experienced in allogeneic hematopoietic stem cell transplantation (allo-HSCT).

For complete prescribing information, including indications, contraindications, warnings, and precautions, please refer to the official EU SmPC.


External Links

This website may contain links to third-party websites, including external regulatory or scientific resources. Cordex Biologics is not responsible for the content, availability, or privacy practices of external websites.


Intellectual Property

All content on this website, including text, graphics, logos, images, and other materials, is the property of Cordex Biologics or its licensors and is protected by applicable intellectual property laws.

Certain images or illustrations displayed on this website may have been generated or enhanced using artificial intelligence tools. Any resemblance to existing copyrighted works, trademarks, products, or visual identities is unintentional.

No part of this website may be reproduced, distributed, modified, or transmitted without prior written permission from Cordex Biologics.


Limitation of Liability

Cordex Biologics takes reasonable measures to ensure that the information provided on this website is accurate, complete, current, and consistent with the approved Summary of Product Characteristics (SmPC) at the time of publication. The content will be updated or modified as necessary to reflect changes in the approved product information or applicable regulatory requirements.

To the extent permitted by applicable law, Cordex Biologics shall not be liable for any damages arising from the use of this website.


Last updated: July 2026